RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- FY22 Strategic Update
- Rhythm Betters ColoSTAT Results
- Rhythm Extends ColoSTAT Clinical Trial to Western Australia
- Rhythm Retains ISO13485 Certification
- Study 6 Successfully Concluded - Exceptional Results
Later from Rhythm Biosciences
- Rhythm to Present at MST Access Investor Conference
- Rhythm Establishes US Entity To Drive US Expansion Strategy
- Non renouneable rights issue prospectus
- Rights Issue Investor Presentation
- Non Renounceable pro rata offer - Completion of despatch
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences